Skip to main content
OpenTrials

Clinical trial condition

Telangiectasia, Hereditary Hemorrhagic

Explore clinical trials studying Telangiectasia, Hereditary Hemorrhagic. Study availability and eligibility vary by location and protocol.

19 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Telangiectasia, Hereditary Hemorrhagic trial results

Completed

Pomalidomide for the Treatment of Bleeding in HHT

NCT03910244

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCSD Hemophilia and Thrombosis Treatment Center San Diego, California, United States
  • UCSF Outpatient Hematology Clinic San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
View all 14 locations
View Trial Details
Completed

North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

NCT01408030

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Georgia Regents University Augusta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions